Skip to main content
Logo

Search form

  • Home
  • Who we are
    • About Synnovis
    • Our people
    • Our services
    • Innovation
    • Quality
  • What we do
    • Departments and laboratories
    • Phlebotomy training
    • Primary Care Information Centre
    • Swiftqueue
  • Tests and results
    • Test index
    • Tests A-Z
    • Test information
    • UKAS Accreditation
  • Service Users
    • Secondary Care NHS Trusts
    • Primary Care Information Centre
    • Private Users
  • Resources
    • News and press
    • Articles and papers
    • Synnovis Policies, User Guides and Documents
    • Transformation
    • Cyberattack Information
  • Join us
    • Your career
    • Working with us
    • Career pathways
    • Current vacancies
    • Training and development
  • Contact us
    • Locations
    • Key contacts
    • Commercial Testing & Partnership Enquiries
    • Customer service
  • Welcome, Sign in or Register
Menu

The National Diagnostic Epidermolysis Bullosa (EB) Laboratory at Guy's Hospital

The National Diagnostic Epidermolysis Bullosa Laboratory provides skin biopsy and gene mutation analysis for patients with the inherited forms of skin fragility or blistering known as epidermolysis bullosa (EB). 

For EB related cases, it is usually necessary that we receive a biopsy sample prior to undertaking mutation analysis. This enables us to identify the candidate gene to be screened. There are at least 15 genes that cause forms of EB and some of these are very large. It would be impractical to undertake molecular screening without first confirming the diagnosis of EB subtype from skin biopsy examination.

For other genodermatoses, please contact the laboratory for the list of genes for mutation analysis.
For prenatal diagnosis, it is important to contact the laboratory well in advance to check availability for these tests.

We are part of the National Specialised Commissioning Group (NSCG) service for people with EB in the UK, and have links with Great Ormond Street Hospital, Birmingham Children's Hospital and Sollihul Hospital. 

The EB laboratory also undertakes diagnosis of a number of other inherited epithelial disorders, including some types of ichthyosis and certain forms of ectodermal dysplasia. 

Guidelines for sending samples
PDF (181Kb)

SE GLH Skin Request Form

PDF (738Kb)

Prenatal diagnosis is provided for severe forms of EB, either by electron microscopy and immunohistochemistry examination of fetal skin biopsies, or by mutation analysis from chorionic villus samples or amniocentesis. Prenatal diagnosis for other genodermatoses is sometimes performed, but individual requests should be discussed with the laboratory leads directly. 

This diagnostic service developed from academic and clinical studies carried out over more than 30 years at St John's Institute of Dermatology. We continue to have close ties with the Genetic Skin Disease Group (King's College London) and undertake numerous collaborative studies, thus remaining at the forefront of genodermatoses research and EB diagnostics. 

Our Customers

For EB cases originating within UK regions covered by the NCG service (England and Wales), the first contact should be made to the appropriate clinical centre: the EB Team at Birmingham Children’s Hospital or Solihull Hospital for children and adults in the north; the EB team at Great Ormond Street Hospital or St John’s Dermatology Centre at St Thomas’ Hospital for children and adults in the south. For referrals from Scotland, contact the Department of Dermatology at the Old Royal Infirmary of Edinburgh. For EB cases originating in Ireland or overseas, the first contact should be made directly with the EB laboratory. 

More information on GSTT website

  • Departments and laboratories
  • Phlebotomy training
  • Primary Care Information Centre
  • Swiftqueue
Last updated on 05/08/2021
  • Articles and papers
  • our people
  • Contacts
view our tests
Monday, 2 November, 2015
The cytolinker plectin regulates nuclear mechanotransduction in keratinocytes.
Almeida FV , Walko G , , McGrath JA , Wiche G , Barber AH , Connelly JT
Saturday, 22 August, 2015
Novel autosomal dominant mutation in loricrin presenting as prominent ichthyosis.
Pohler E , Cunningham F , Sandilands A , Cole C , Digby S , , Aristodemou S , McGrath JA , Smith FJ , McLean WH , Munro CS , Zamiri M
List Grid
Dr Lu Liu
Head of Molecular Diagnostic

The National Diagnostic Epidermolysis Bullosa (EB) Laboratory at Guy's

020 7188 7229
eblab@synnovis.co.uk
Research Oncology Lab Unit
3rd floor Bermondsey Wing
Guy's Hospital
London SE1 9RT

Last updated: 05/08/2021

eMail alerts and news

Sign up with Viapath to receive our newsletter and hear about our scientific events.
Privacy policy

Follow us

Twitter LinkedIn RSS

Site details

  • Privacy policy
  • Cookies
  • Terms of use
  • Accessibility
  • Feedback

Working with our NHS service partners to set the standard for the future of pathology

 

Gyu's and St Thomas'
King's College Hospital

 

Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. 

Copyright 2014-2025 Synnovis Group LLP. Synnovis, the Synnovis logo and Nutris are registered trademarks of Synnovis Group LLP.

Home
Who we are
  • About Synnovis
  • Our people
  • Our services
  • Innovation
  • Quality
What we do
  • Departments and laboratories
  • Phlebotomy training
  • Primary Care Information Centre
  • Swiftqueue
Our tests
  • Test index
  • Tests A-Z
  • Test information
  • UKAS Accreditation
Service users
News and media
  • News and press
  • Articles and papers
  • Synnovis Policies, User Guides and Documents
  • Transformation
  • Cyberattack Information
Careers
  • Your career
  • Working with us
  • Career pathways
  • Current vacancies
  • Training and development
Contact us
  • Locations
  • Key contacts
  • Commercial Testing & Partnership Enquiries
  • Customer service
Close menu